Clear All
11765 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
50881-0005-60 50881-0005 Ruxolitinib Jakafi 5.0 mg/1 Chemotherapy Enzyme Inhibitor JAK 1/2 Oral Nov 16, 2011 In Use
68001-0552-41 68001-0552 Pemetrexed disodium Pemetrexed 850.0 mg/34mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Sep 7, 2022 In Use
59923-0712-14 59923-0712 temozolomide TEMOZOLOMIDE 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Jan 25, 2019 In Use
00009-1111-01 00009-1111 Irinotecan Hydrochloride Camptosar 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Jun 14, 1996 Oct 31, 2017 In Use
64144-0504-02 64144-0504 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Apr 13, 2016 In Use
25021-0245-01 25021-0245 Docetaxel Anhydrous Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Sep 15, 2017 In Use
16729-0522-64 16729-0522 Pemetrexed disodium Pemetrexed 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Sep 8, 2022 Jan 22, 2025 No Longer Used
83831-0131-01 83831-0131 Pemetrexed AXTLE 100.0 mg/4mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous Jan 1, 2025 In Use
68382-0775-01 68382-0775 Methotrexate Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Feb 9, 2017 In Use
72064-0210-90 72064-0210 pralsetinib GAVRETO 100.0 mg/1 Chemotherapy Enzyme Inhibitor RET, DDR1, TRKC, FLT3, JAK1/2, TRKA, VEGFR2, PDGFRB, FGFR1 Oral Sep 4, 2020 Apr 30, 2022 No Longer Used
67457-0429-20 67457-0429 Ifosfamide Ifosfamide 50.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Nov 27, 2012 Dec 31, 2017 No Longer Used
62856-0710-30 62856-0710 Lenvatinib Lenvima 10.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FGF, PDGFR, KIT, RET Oral Feb 13, 2015 In Use
00173-0752-00 00173-0752 Lapatinib TYKERB 250.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR/HER2 Oral Mar 16, 2007 Nov 30, 2017 No Longer Used
43066-0001-01 43066-0001 docetaxel Docetaxel 10.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Feb 19, 2018 In Use
68001-0442-26 68001-0442 cyclophosphamide Cyclophosphamide 500.0 mg/25mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous, Oral Oct 19, 2020 In Use
16571-0818-51 16571-0818 Temozolomide TEMOZOLOMIDE 100.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Oct 4, 2022 In Use
00703-3015-13 00703-3015 Fluorouracil Adrucil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Oct 1, 2003 Oct 31, 2020 No Longer Used
72266-0162-01 72266-0162 Oxaliplatin Oxaliplatin 5.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Mar 30, 2020 In Use
00015-0505-41 00015-0505 Cyclophosphamide Cytoxan Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Jun 1, 2009 Nov 30, 2011 No Longer Used
68118-0100-01 68118-0100 Streptozocin Zanosar 1.0 g/10mL Chemotherapy Alkylating Agent Nitrosourea Intravenous May 19, 2025 In Use
23155-0355-41 23155-0355 Melphalan hydrochloride Melphalan hydrochloride 50.0 mg/10mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Mar 28, 2025 In Use
68083-0484-01 68083-0484 MITOMYCIN MITOMYCIN 20.0 mg/40mL Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Oct 20, 2021 In Use
71288-0185-10 71288-0185 Idarubicin Hydrochloride Idarubicin Hydrochloride 1.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jun 1, 2025 In Use
69097-0578-91 69097-0578 nilotinib NILCEYA 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral May 30, 2025 In Use
65219-0131-20 65219-0131 Cyclophosphamide Cyclophosphamide 1.0 g/50mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Nov 17, 2023 In Use

Found 11765 results — Export these results